Symrise (FRA:SY1 – Get Rating) received a €107.00 ($111.46) price objective from research analysts at JPMorgan Chase & Co. in a research note issued to investors on Monday, Borsen Zeitung reports. JPMorgan Chase & Co.‘s target price suggests a potential upside of 9.99% from the stock’s current price.
Other research analysts have also issued reports about the stock. Warburg Research set a €102.00 ($106.25) price target on shares of Symrise in a research note on Tuesday, May 10th. Credit Suisse Group set a €117.00 ($121.88) price objective on shares of Symrise in a research note on Wednesday, March 9th. Jefferies Financial Group set a €125.00 ($130.21) price objective on shares of Symrise in a research note on Friday, May 27th. Berenberg Bank set a €119.00 ($123.96) price objective on shares of Symrise in a research note on Thursday, March 24th. Finally, Deutsche Bank Aktiengesellschaft set a €138.00 ($143.75) price objective on shares of Symrise in a research note on Wednesday, March 2nd.
Shares of Symrise stock opened at €97.28 ($101.33) on Monday. The company has a 50-day moving average of €104.95 and a 200 day moving average of €110.50. Symrise has a 1 year low of €56.96 ($59.33) and a 1 year high of €73.48 ($76.54).
Symrise Company Profile (Get Rating)
Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.
See Also
Receive News & Ratings for Symrise Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Symrise and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
